Nectar Life Sciences Limited, a active public limited company, was established on 27 June 1995 in Punjab, Punjab, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24232PB1995PLC016664. Registered under ROC Roc Chandigarh. it is listed on BSE: 532649 and NSE: NECLIFE. It has an authorized capital of ₹35.00 Cr and a paid-up capital of ₹22.43 Cr.
Formerly known as Surya Medicare Limited. It upholds a compliant status. In 2024, it reported revenue of ₹1,698.66 Cr and a net worth of ₹1,069.25 Cr. Employing 1,618 professional, Its leadership includes Rupinder Tewari (Director), Sanjiv Goyal (Managing Director), Indu Pal Kaur (Director). Past directors included Ajay Swaroop, Rupinder Tewari, Raman Kapur. It holds ₹6.05 M open charges and ₹6,248.83 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at Vill Said Purateh Dera Bassi Distt Patiala, Punjab, Punjab.
L24232PB1995PLC016664
016664
27 June 1995
₹35.00 Cr
₹22.43 Cr
Roc Chandigarh
Listed (BSE: 532649, NSE: NECLIFE)
Active
Explore comprehensive insights into Nectar Life Sciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rupinder Tewari | Director | 11 Feb 2019 | Current |
| Sanjiv Goyal | Managing Director | 27 Jun 1995 | Current |
| Indu Pal Kaur | Director | 02 Aug 2022 | Current |
| Kuldip Kumar Bhasin | Director | 21 Sep 2021 | Current |
| Meena Virbhan Verma | Nominee Director | 11 Feb 2019 | Current |
| Surulichamy Senthilkumar | Whole-Time Director | 01 Jun 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2010 | Past |
| Pramod Abcsdd | Director | 01 Oct 2009 | Past |
| Pramod Abcsdd | Director | 22 Jan 2007 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nectar Life Sciences Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 8.41% increase. The company also saw a substantial improvement in profitability, with a 122.27% increase in profit. The company's net worth moved up by a moderate rise of 0.44%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Nectar Life Sciences had a promoter holding of 44.35% and a public holding of 55.65%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹6,047,200.00
₹62,488,323,702.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Dec 2023 | Hdfc Bank Limited | ₹6.05 M | Open |
| 28 Jun 2022 | Hdfc Bank Limited | ₹2.00 M | Satisfied |
| 01 Dec 2021 | Hdfc Bank Limited | ₹2.00 M | Satisfied |
| 14 Jul 2021 | Hdfc Bank Limited | ₹0.60 M | Satisfied |
| 21 Jun 2021 | Sbicap Trustee Company Limited | ₹1,338.35 Cr | Satisfied |
Explore comprehensive loan charge details -
Nectar Life Sciences has a workforce of 1618 employees as of Mar 05, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Nectar Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nectar Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 21 Jun 2021 via Charge ID 100458233 with Sbicap Trustee Company Limited was fully satisfied on 21 Oct 2025. was recorded as a recent event.
The activity Nectar Life Sciences Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was completed.
The activity A charge registered on 28 Jun 2022 via Charge ID 100593892 with Hdfc Bank Limited was fully satisfied on 01 Aug 2025. was completed.
A charge registered on 01 Dec 2021 via Charge ID 100511693 with Hdfc Bank Limited was fully satisfied on 03 Jul 2025. was recorded as a recent event.
Surulichamy Senthilkumar was appointed as a Whole-time director was appointed as a Whole-time director on 01 Jun 2025 & has been associated with this company since 5 months 28 days . was recorded as a recent event.
Sanjaymohan Singh Rawat was appointed as a Company Secretary was appointed as a Company Secretary on 02 Apr 2025 & has been associated with this company since 7 months 27 days . was recorded as a recent event.
When you thought you had a chance to acquire Orchid Pharma, but then Strides Shasun, Nectar Lifesciences, and Blackstone swoop in and steal the deal. Aurobindo and Dr. Reddy's backed out, leaving only 10 offers on the table. The company is facing financial claims of Rs 3,500 crore and has received interest from various groups, including Edelweiss and Phoenix ARC. Indian API manufacturers are struggling against Chinese competition, leading to the government setting up a taskforce to encourage domestic production. Orchid Pharma's shares closed at Rs 17, down 5%..
The CIN of Nectar Life Sciences Limited is L24232PB1995PLC016664.
Nectar Life Sciences Limited is headquartered at Vill Said Purateh Dera Bassi Distt Patiala, Punjab, Punjab.
Nectar Life Sciences Limited was incorporated on 27 June 1995.
The current directors of Nectar Life Sciences Limited are
The primary industry of Nectar Life Sciences Limited is Manufacturing.
Nectar Life Sciences Limited is listed. It is listed on BSE: 532649 and NSE: NECLIFE.
The authorized capital of Nectar Life Sciences Limited is ₹35.00 Cr, and the paid-up capital is ₹22.43 Cr.
The compliance status of Nectar Life Sciences Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX